TCM Biotech International Balance Sheet Health
Financial Health criteria checks 5/6
TCM Biotech International has a total shareholder equity of NT$1.1B and total debt of NT$108.9M, which brings its debt-to-equity ratio to 10.3%. Its total assets and total liabilities are NT$1.3B and NT$267.9M respectively. TCM Biotech International's EBIT is NT$22.3M making its interest coverage ratio 18.2. It has cash and short-term investments of NT$504.1M.
Key information
10.3%
Debt to equity ratio
NT$108.89m
Debt
| Interest coverage ratio | 18.2x |
| Cash | NT$504.13m |
| Equity | NT$1.06b |
| Total liabilities | NT$267.88m |
| Total assets | NT$1.32b |
Recent financial health updates
Recent updates
Can You Imagine How TCM Biotech International's (GTSM:4169) Shareholders Feel About The 28% Share Price Increase?
Jan 31
Key Things To Consider Before Buying TCM Biotech International Corp. (GTSM:4169) For Its Dividend
Jan 04We Think TCM Biotech International (GTSM:4169) Can Stay On Top Of Its Debt
Dec 07
Financial Position Analysis
Short Term Liabilities: 4169's short term assets (NT$981.2M) exceed its short term liabilities (NT$198.4M).
Long Term Liabilities: 4169's short term assets (NT$981.2M) exceed its long term liabilities (NT$69.5M).
Debt to Equity History and Analysis
Debt Level: 4169 has more cash than its total debt.
Reducing Debt: 4169's debt to equity ratio has reduced from 26.6% to 10.3% over the past 5 years.
Debt Coverage: 4169's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 4169's interest payments on its debt are well covered by EBIT (18.2x coverage).